(Q42652660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

main subject

Pseudomonas aeruginosa

0 references

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Lisa Saiman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Nicole Mayer-Hamblett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Michael Anstead

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Larry C Lands

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Margaret Kloster

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Lynn M Rose

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jane L Burns

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Bruce C Marshall

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Felix Ratjen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

AZ0004 Macrolide Study Team

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

1 reference

3 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

published in

Pediatric Pulmonology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

641-648

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Pulmonary function between 6 and 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Microbiology of sputum from patients at cystic fibrosis centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Macrolide antibiotics for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

The role of azithromycin in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

The use of macrolide antibiotics in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21601

21 January 2018

Identifiers

DOI

10.1002/PPUL.21601

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22684984%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference